Cancer cachexia is a complex multi‐organ catabolic syndrome that reduces mobility,
increases fatigue, decreases the efficiency of therapeutic strategies, diminishes the quality of …

Research investigators have shown a growing interest in investigating alterations underlying
skeletal muscle wasting in patients with cancer. However, skeletal muscle dysfunctions …

Cancer cachexia is a systemic hypoanabolic and catabolic syndrome that diminishes the
quality of life of cancer patients, decreases the efficiency of therapeutic strategies and …

Background Cancer cachexia is a complex syndrome related to a negative energy balance
resulting in muscle wasting. Implication of muscle mitochondrial bioenergetics alterations …

Purpose. Cancer-related cachexia is an obscure syndrome leading to muscle wasting,
reduced physical fitness and quality of life. The aim of this study was to assess morphology …

Cancer cachexia is a frequently neglected debilitating syndrome that, beyond representing a
primary cause of death and cancer therapy failure, negatively impacts on patients' quality of …

Background Cachexia is a multi-factorial, systemic syndrome that especially affects patients
with cancer of the gastrointestinal tract, and leads to reduced treatment response, survival …

Background Progressive loss of muscle mass is a major characteristic of cancer cachexia.
Consensus definitions for cachexia provide different options to measure muscle mass. This …

Background Cachexia affects the majority of patients with advanced cancer and is
associated with a reduction in treatment tolerance, response to therapy, and duration of …

Cancer cachexia is a complex metabolic syndrome that is characterized by the loss of
skeletal muscle mass and weakness, which compromises physical function, reduces quality …